December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.

December 7, 2007 — GE Healthcare has licensed a technique patented by an Eastern Virginia Medical School (EVMS) obstetrician that can automate the acquisition of ultrasound images used by physicians to diagnose fetal heart defects.

GE has licensed the software for exclusive use in its 3D/4D ultrasound systems. Alfred Abuhamad, M.D., chairman of obstetrics and gynecology at EVMS developed the automation protocol, called Sonography based Volume Computer Aided Diagnosis (SonoVCAD).

December 7, 2007 - Cardinal Health and HemCon Medical Technologies Inc. this week announced the availability of co-labeled chitosan-based hemorrhage control dressings to acute care professionals as part of an exclusive, four-year distribution agreement.

Cardinal Health now offers various sizes of the HemCon Bandage and ChitoFlex dressings to first responders and medical professionals in emergency rooms, trauma care, and cardiac catheterization labs.

December 7, 2007 – The Siemens “Win an MRI" contest has closed and the polls are now open to award a MAGNETOM Essenza MRI system to rural and community hospitals, with fewer than 180 beds who do not have fixed MRI services.
The prize, a MAGNETOM Essenza, was introduced to the market in October 2007 and was developed specifically for the small hospital market, and expected to help physicians deliver improved imaging services in neurology, orthopedics, body imaging, angiography, cardiology, breast imaging, oncology and pediatric imaging.

December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was performed by the Cardiovascular Surgery Division at Mayo Clinic in Rochester, MN, announced The Sorin Group.

Designed to provide high hemodynamic performance and ease of implant, the Mitroflow valve received FDA approval in October 2007 and is now available to cardiac surgeons and their patients in the U.S.

December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer laser face, according to an article in the Journal of Interventional Cardiology, researchers from the University of California , Davis Medical Center review state-of-the-art treatment for vessel punctures.

Catheters outfitted with balloons, lasers and miniature drills have made the treatment of blocked arteries virtually routine. Now physicians are using the same technology used to open clogged arteries to repair ruptures and perforations with less risk.

December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with conditions the PROMUS/ XIENCE V everolimus-eluting coronary stent system, marking a significant step toward making Boston Scientific's two-drug program a reality in the U.S.

The PROMUS and XIENCE V stent systems are identical products, sold respectively by Boston Scientific and Abbott in international markets. Both stent systems would be covered by the same FDA approval.

December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V Everolimus Eluting Coronary Stent System, a next-generation drug eluting stent intended for use in the treatment of coronary artery disease.

The FDA advisory committee voted to recommend the XIENCE V stent system for approval with conditions related to post-marketing study requirements and language related to dual antiplatelet therapy.

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan

December 6, 2007 - At this year’s RSNA more PACS vendors were showing off the expanded 3D capabilities of their PACS offering and highlighting some of their partnerships with third-party vendors, particularly the more productive ones that have led to deeper levels of integration.

By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now